Literature DB >> 11872886

Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers.

Alexander X Halim1, Vineeta Singh, S Claiborne Johnston, Randall T Higashida, Christopher F Dowd, Van V Halbach, Michael T Lawton, Daryl R Gress, Charles E McCulloch, William L Young.   

Abstract

BACKGROUND: Patients harboring a brain arteriovenous malformation (BAVM) often have coexisting arterial aneurysms. Experts have argued about the clinical significance of these aneurysms, which may be important for risk stratification in patient management and clinical trials. We studied the association between coexisting aneurysms and initial presentation with intracranial hemorrhage (ICH) in patients with BAVM evaluated at two tertiary-care centers.
METHODS: Demographic and clinical data were collected from a prospective series of patients evaluated for BAVM at the University of California, San Francisco (UCSF; n=82), and Columbia-Presbyterian Medical Center, New York (CPMC; n=254). Using multivariate logistic regression, we examined the independent association between ICH presentation and the presence of a coexisting aneurysm, and compared the association at the two hospitals.
RESULTS: Aneurysms were associated with 28 BAVMs at UCSF (34%) and 74 at CPMC (29%; P=0.39). Initial presentation with ICH was associated with the presence of a coexisting aneurysm at CPMC (odds ratio 1.8, 95% confidence interval 1.0 to 3.0, P=0.044). The opposite trend was observed at UCSF (odds ratio 0.4, 95% confidence interval 0.2 to 1.1, P=0.085). We observed an interaction by site involving the association between ICH presentation and aneurysm (P=0.016).
CONCLUSION: Although many BAVM characteristics were similar at the referral centers studied, the association between initial presentation with ICH and coexisting aneurysms was not. This heterogeneity between populations undermines the validity of inferences on the role of aneurysms from any single referral series, and emphasizes the complexity in creating BAVM risk-stratification models that incorporate aneurysms.

Entities:  

Mesh:

Year:  2002        PMID: 11872886     DOI: 10.1161/hs0302.104104

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Authors:  Ludmila Pawlikowska; K Y Trudy Poon; Achal S Achrol; Charles E McCulloch; Connie Ha; Kristen Lum; Jonathan G Zaroff; Nerissa U Ko; S Claiborne Johnston; Stephen Sidney; Douglas A Marchuk; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.

Authors:  Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su
Journal:  Neuroimmunol Neuroinflamm       Date:  2014

3.  Morphologic Change of Flow-Related Aneurysms in Brain Arteriovenous Malformations after Stereotactic Radiosurgery.

Authors:  Y-S Tsuei; C-B Luo; L-Y Fay; H-C Yang; W-Y Guo; H-M Wu; W-Y Chung; M M H Teng
Journal:  AJNR Am J Neuroradiol       Date:  2019-04       Impact factor: 3.825

4.  Endovascular treatment of intracranial ruptured aneurysms associated with arteriovenous malformations: a clinical analysis of 14 hemorrhagic cases.

Authors:  J-L Yu; S Yang; Q Luo; H-L Wang; B Wang; Y-Y Qu; K Xu
Journal:  Interv Neuroradiol       Date:  2011-04-29       Impact factor: 1.610

5.  Complication analysis of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate.

Authors:  T L Li; B Fang; X Y He; C Z Duan; Q J Wang; Q P Zhao; Q Yi Fm Huan
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

6.  Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms.

Authors:  Nasrine Bendjilali; Jeffrey Nelson; Shantel Weinsheimer; Stephen Sidney; Jonathan G Zaroff; Steven W Hetts; Mark Segal; Ludmila Pawlikowska; Charles E McCulloch; William L Young; Helen Kim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-28       Impact factor: 10.154

7.  G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation.

Authors:  Shantel Weinsheimer; Ari D Brettman; Ludmila Pawlikowska; D Christine Wu; Michael R Mancuso; Frank Kuhnert; Michael T Lawton; Stephen Sidney; Jonathan G Zaroff; Charles E McCulloch; William L Young; Calvin Kuo; Helen Kim
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

8.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

Review 9.  Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations.

Authors:  W Caleb Rutledge; Nerissa U Ko; Michael T Lawton; Helen Kim
Journal:  Transl Stroke Res       Date:  2014-06-15       Impact factor: 6.829

10.  Evidence of inflammatory cell involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young
Journal:  Neurosurgery       Date:  2008-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.